R. Locicero

Results of a multicenter pilot study of weekly nab-paclitaxel, carboplatin with bevacizumab, and trastuzumab as neoadjuvant therapy in HER2+ locally advanced breast cancer with SPARC correlatives.

D. Yardley, N. Desai, V. Trieu, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of neoadjuvant weekly nab-paclitaxel and carboplatin, with bevacizumab and trastuzumab, as treatment for women with locally advanced HER2+ breast cancer.

J. Hainsworth, H. Burris, D. Yardley, 2011, Clinical breast cancer.

A Rare Case of Advance Goblet Cell Carcinoma and a Narrative Review

E. Molmenti, Santiago J. Miyara, Sheena R. Bhushan, 2022, Current Problems in Cancer: Case Reports.

Nonoperative management of blunt splenic trauma: a multicenter experience.

J. Morris, S. Shackford, M. Farnell, 1989, The Journal of trauma.

A Phase II Study of FOLFOXIRI Plus Panitumumab Followed by Evaluation for Resection in Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only

J. Bendell, M. Moskowitz, D. Waterhouse, 2016, The oncologist.

Equal Effectiveness of Very—Low‐Intensity Anticoagulation and Standard Low‐Intensity Anticoagulation: A Pilot study

W. Brehm, R. Locicero, D. Berdeaux, 1995, Southern medical journal.